Zobrazeno 1 - 10
of 379
pro vyhledávání: '"Takeshi NAKAHARA"'
Autor:
Takeshi Nakahara, Shinichi Noto, Miyuki Matsukawa, Hiroe Takeda, Yilong Zhang, Tomohiro Kondo
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 11, Pp 3113-3132 (2024)
Abstract Introduction Difamilast has proven to be an effective treatment for the treatment of atopic dermatitis (AD) in Japan, but its cost-effectiveness remains unknown. Therefore, the objective of the current study was to determine the cost-effecti
Externí odkaz:
https://doaj.org/article/b342b926897a49508713b5b5537a1d01
Autor:
Takeshi Nakahara, Hiroyuki Murota, Miyuki Matsukawa, Hiroe Takeda, Yilong Zhang, Tomohiro Kondo
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 10, Pp 2905-2916 (2024)
Abstract Background Atopic dermatitis (AD) is a chronic condition with an increasing incidence in Japan. Difamilast and delgocitinib are both new topical drugs for AD proven to be efficacious and safe in phases 2 and 3 clinical trials in Japan. Howev
Externí odkaz:
https://doaj.org/article/1bd9952dbcbb4c4ea297268b5d5b1a3b
Autor:
Toshio Ichiki, Takamichi Ito, Sakura Shiraishi, Yasuharu Nakashima, Takeshi Nakahara, Yoshinao Oda
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract PRAME (PReferentially expressed Antigen in MElanoma) was first identified as a malignant melanoma-specific antigen. Recently, a few cases of fibrosarcomatous dermatofibrosarcoma protuberans (FS-DFSP) were shown to have positivity for PRAME,
Externí odkaz:
https://doaj.org/article/ac20694fcc0f44c288a46e532866fd0a
Autor:
Takamichi Ito, Yuka Tanaka, Yumiko Kaku-Ito, Keiko Tanegashima, Mao Imajima, Toshio Ichiki, Takeshi Nakahara
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionCutaneous squamous cell carcinoma (cSCC) is a common form of skin cancer. Less accessibility to the cSCC cell lines has limited analyses of this disease. Thus, we here aimed to establish novel cSCC cell lines from patient's cSCC lesions.M
Externí odkaz:
https://doaj.org/article/ab5d30404b6241278e1f818db8d144b8
Autor:
Makiko Kido-Nakahara, MD, Daisuke Onozuka, PhD, Kenji Izuhara, PhD, Hidehisa Saeki, MD, Satoshi Nunomura, PhD, Motoi Takenaka, MD, Mai Matsumoto, MD, Yoko Kataoka, MD, Rai Fujimoto, MD, Sakae Kaneko, MD, Eishin Morita, MD, Akio Tanaka, MD, Michihiro Hide, MD, Tatsuro Okano, MD, Tomomitsu Miyagaki, MD, Natsuko Aoki, MD, Kimiko Nakajima, MD, Susumu Ichiyama, MD, Kyoko Tonomura, MD, Yukinobu Nakagawa, MD, Risa Tamagawa-Mineoka, MD, Koji Masuda, MD, Takuya Takeichi, MD, Masashi Akiyama, MD, Yozo Ishiuji, MD, Michie Katsuta, MD, Yuki Kinoshita, MD, Chiharu Tateishi, MD, Aya Yamamoto, MD, Akimichi Morita, MD, Haruna Matsuda-Hirose, MD, Yutaka Hatano, MD, Hiroshi Kawasaki, MD, Keiji Tanese, MD, Mamitaro Ohtsuki, MD, Koji Kamiya, MD, Yudai Kabata, MD, Riichiro Abe, MD, Hiroshi Mitsui, MD, Tatsuyoshi Kawamura, MD, Gaku Tsuji, MD, Masutaka Furue, MD, Norito Katoh, MD, Takeshi Nakahara, MD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 4, Pp 100317- (2024)
Background: Atopic dermatitis (AD) is a common chronic eczematous skin disease with severe pruritus. Several new therapeutic agents for AD such as dupilumab, an anti–IL-4Rα antibody, have been developed in recent years. We need to predict which ag
Externí odkaz:
https://doaj.org/article/442b55c6ab214b19b904fcdf110b4187
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Extramammary Paget disease (EMPD) is a rare skin cancer that primarily affects older individuals predominantly in areas with apocrine sweat glands. Although most early EMPD lesions are indolent, patients with metastatic EMPD have a poor prog
Externí odkaz:
https://doaj.org/article/5c14fa929d17408e8c4e167e150862d1
Autor:
Makiko Kido-Nakahara, Daisuke Onozuka, Kenji Izuhara, Hidehisa Saeki, Satoshi Nunomura, Motoi Takenaka, Mai Matsumoto, Yoko Kataoka, Rai Fujimoto, Sakae Kaneko, Eishin Morita, Akio Tanaka, Ryo Saito, Tatsuro Okano, Tomomitsu Miyagaki, Natsuko Aoki, Kimiko Nakajima, Susumu Ichiyama, Kyoko Tonomura, Yukinobu Nakagawa, Risa Tamagawa-Mineoka, Koji Masuda, Takuya Takeichi, Masashi Akiyama, Yozo Ishiuji, Michie Katsuta, Yuki Kinoshita, Chiharu Tateishi, Aya Yamamoto, Akimichi Morita, Haruna Matsuda-Hirose, Yutaka Hatano, Hiroshi Kawasaki, Ayano Fukushima-Nomura, Mamitaro Ohtsuki, Koji Kamiya, Yudai Kabata, Riichiro Abe, Hiroshi Mitsui, Tatsuyoshi Kawamura, Gaku Tsuji, Masutaka Furue, Norito Katoh, Takeshi Nakahara
Publikováno v:
Allergology International, Vol 73, Iss 2, Pp 332-334 (2024)
Externí odkaz:
https://doaj.org/article/70272fe7bce744dab7bd11fc8d371fcb
Publikováno v:
Indian Journal of Dermatology, Vol 69, Iss 3, Pp 276-277 (2024)
Externí odkaz:
https://doaj.org/article/a0ba0509b4414bc08c9e822333585b2e
Autor:
Yukihiro Ohya, Toshiya Ebata, Yusei Ohshima, Tsugunobu Andoh, Mitsutoshi Tominaga, Yoko Kataoka, Yoshinori Fukui, Nobuyuki Ebihara, Shunji Hasegawa, Shigetoshi Kobayashi, Yutaka Morisawa, Norihiro Inoue, Masami Narita, Sakae Kaneko, Ken Igawa, Takeshi Nakahara, Yozo Ishiuji, Takaharu Okada, Masanori Fujii, Hiroshi Kawasaki, Hiroyuki Irie, Miho Shiratori-Hayashi, Hiroyuki Murota
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 7 (2024)
Background: The nature of itch sensation varies depending upon the patient and the disease. However, few studies have focused on verbal expressions describing itch of atopic dermatitis (AD) in quality.Objectives: To investigate itch quality in patien
Externí odkaz:
https://doaj.org/article/4f846319ae3b45e19745494433ba0a6c
Autor:
Takeshi Nakahara, MD, PhD, Daisuke Onozuka, PhD, Satoshi Nunomura, PhD, Hidehisa Saeki, MD, PhD, Motoi Takenaka, MD, PhD, Mai Matsumoto, MD, PhD, Yoko Kataoka, MD, Rai Fujimoto, MD, PhD, Sakae Kaneko, MD, PhD, Eishin Morita, MD, PhD, Akio Tanaka, MD, PhD, Ryo Saito, MD, PhD, Tatsuro Okano, MD, PhD, Tomomitsu Miyagaki, MD, PhD, Natsuko Aoki, MD, PhD, Kimiko Nakajima, MD, PhD, Susumu Ichiyama, MD, PhD, Makiko Kido-Nakahara, MD, PhD, Kyoko Tonomura, MD, PhD, Yukinobu Nakagawa, MD, PhD, Risa Tamagawa-Mineoka, MD, PhD, Koji Masuda, MD, PhD, Takuya Takeichi, MD, PhD, Masashi Akiyama, MD, PhD, Yozo Ishiuji, MD, PhD, Michie Katsuta, MD, PhD, Yuki Kinoshita, MD, PhD, Chiharu Tateishi, MD, PhD, Aya Yamamoto, MD, PhD, Akimichi Morita, MD, PhD, Haruna Matsuda-Hirose, MD, PhD, Yutaka Hatano, MD, PhD, Hiroshi Kawasaki, MD, PhD, Ayano Fukushima-Nomura, MD, Mamitaro Ohtsuki, MD, PhD, Koji Kamiya, MD, PhD, Yudai Kabata, MD, PhD, Riichiro Abe, MD, PhD, Hiroshi Mitsui, MD, PhD, Tatsuyoshi Kawamura, MD, PhD, Gaku Tsuji, MD, PhD, Norito Katoh, MD, PhD, Masutaka Furue, MD, PhD, Kenji Izuhara, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 1, Pp 100175- (2024)
Background: To develop precision medicine for atopic dermatitis (AD), it is critical to establish relevant biomarkers. However, the characteristics of various biomarkers have not been fully understood. We previously carried out the Biomarkers to Pred
Externí odkaz:
https://doaj.org/article/e11f03b3ae004428bb4cca14383d8c63